HOME >> BIOLOGY >> NEWS
Race Plus Roaches: A Breathtaking Link

African-Americans are far more likely than Caucasians to develop asthma linked to cockroach sensitivity, according to research from the Johns Hopkins Children's Center.

In a recent study of more than 80 Baltimore youth, the researchers found that an African-American child was 16.4 times more likely than a Caucasian child to be sensitive to allergens left behind by cockroach droppings and saliva. And poor children or those from out of cities were 11.9 times more likely to be affected by roach infestation than those from middle or high income families.

The study in the June issue of The Journal of Allergy and Clinical Immunology is also the first to report that children in the most infested homes are the most sensitive to the allergens, a clear indication of dose responsiveness, the researchers say.

"We honestly don't know why race plays a role independent of poverty," says Peyton Eggleston, M.D., professor of pediatrics and co-author of the study. Eggleston speculates that racially based genetic differences, important in the regulation of immune responses, hold a clue.

Low socioeconomic status forces families to live in substandard housing, whether urban or suburban, he says. Older homes, or those in crowded areas, give cockroaches a fertile breeding ground.

The domestic cockroach has been identified as a source of indoor allergen worldwide, both in temperate and tropical climates. Although more than 60 species have been identified, the most common in North America are the German, Oriental, and American cockroaches.

Cockroach allergens are known to represent an important risk factor for acute asthma, a condition that causes the bronchi of the lungs to constrict. Onset almost always occurs in childhood. Serious illness and even death can result. For example, in Baltimore City, where the study was conducted, asthma is the number one cause of absenteeism from school, says Eggleston. And recent epidemiologic data show that African-Americans livi
'"/>

Contact: Debbie Bangledorf
dbangled@welchlink.welch.jhu.edu
410-955-4948
Johns Hopkins Medical Institutions
11-Jun-1996


Page: 1 2

Related biology news :

1. Mutated protein combination tied to excessive sugar production
2. Study Reveals Cancer Role Of Mutated Gene
3. Bone Marrow Gives Rise To Functioning Liver Cells, University Of Pittsburgh Scientists Discover
4. Bugscope Gives Internet Users Anywhere Chance To Study Insects
5. Glowing Cyanobacteria Gives Researchers New Clues To Circadian Rhythms
6. Technique Gives Researchers New Look At Genetic Activity In Living Cells
7. Suicide Response Gives Colorado State Researchers Important Clues On Preventing Bacterial Invasion In Crops Worldwide
8. Widespread Genus Of Monkeys Gives Up Genealogical Secrets To Columbia Researchers
9. Yeast mutations offer window into human disease
10. Yeast model yields insights into Parkinsons disease
11. Yeast helps researchers better understand Parkinsons mystery

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Race Plus Roaches Breathtaking Link

(Date:12/10/2014)... WINSTON-SALEM, N.C. , Dec. 9, 2014  Wake Forest ... medical education building for its School of Medicine. Funding ... a larger capital campaign that will be publicly launched ... will be located in the former 60 series R.J. ... Forest Innovation Quarter. Construction will begin immediately with plans ...
(Date:12/5/2014)... VIEW, Calif. , Dec. 4, 2014 /PRNewswire/ ... safety has boosted investments in new testing and ... has also given rise to a range of ... by the requirements of Generation Y, which is ... technologies. As a result, product development strategies of ...
(Date:12/3/2014)... , Dec. 2, 2014 As part ... readers, Inception Technologies is pleased to announce the release ... for customers to collect the workforce data that they ... that have been left by existing readers. Many such ... interface, connectivity and modern technology. Older models force users ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
(Date:12/17/2014)... Xeno Diagnostics has again received ... recent COLA inspection. Xeno has met all criteria ... accreditation organization. Accreditation is earned only by laboratories ... operations, demonstrate continued accuracy in the performance of ... survey. , While the Laboratory Excellence ...
(Date:12/17/2014)... , Dec. 17, 2014 CASI Pharmaceuticals, ... dedicated to the acquisition, development and commercialization of innovative ... the global market with a primary commercial focus on ... has been granted a Type C meeting with the ... meeting will be held in February 2015.  During this ...
(Date:12/15/2014)... DIEGO , Dec. 15, 2014 ... three-dimensional biology company focused on delivering breakthrough 3D ... the industry and collaborators of its exVive3D TM ... made widely available in full commercial release on ... the field, resulting in several awards for innovation. ...
(Date:12/13/2014)... and Virgin Unite Canada, the non-profit foundation of the Virgin ... Canadian entrepreneurs tackling social and environmental challenges. Today, Sir ... Centre to announce the new partnership, which includes the development ... $1 million in seed capital provided by Virgin Unite Canada ... Foundation, founded by Alison Lawton . ...
Breaking Biology Technology:Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 2Organovo Celebrates a Positive 2014 Reception of its exVive3DTM Human Liver Tissue Product 3MaRS and Virgin Unite partner to invest in business as a force for good 2MaRS and Virgin Unite partner to invest in business as a force for good 3
Cached News: